Summary
Viz.ai Inc (Viz.ai) is a technology company that specializes in the development of artificial intelligence (AI) solutions for healthcare. The company carries out creating AI-powered care coordination solutions that analyze medical imaging data to provide real-time insights and automated assessments. Its product portfolio includes Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, and Viz Cardio Suite, Radiology Suite, and Trauma Suite. Viz.ai's products are designed to detect diseases, accelerate diagnosis, and improve patient care across a wide range of therapeutic areas. The company solutions are used by healthcare providers, including hospitals and clinicians, to enhance patient outcomes and streamline clinical workflows. Viz.ai is headquartered in San Francisco, California, the US.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Viz.ai Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Viz.ai Inc Company Overview
- Viz.ai Inc Company Snapshot
- Viz.ai Inc Pipeline Products and Ongoing Clinical Trials Overview
- Viz.ai Inc - Pipeline Analysis Overview
- Viz.ai Inc - Key Facts
- Viz.ai Inc - Major Products and Services
- Viz.ai Inc Pipeline Products by Development Stage
- Viz.ai Inc Pipeline Products Overview
- AI Algorithm - Cardiac Amyloidosis
- AI Algorithm - Cardiac Amyloidosis Product Overview
- AI Algorithm - Pulmonary Hypertension
- AI Algorithm - Pulmonary Hypertension Product Overview
- AI Algorithm - Supraventricular Tachycardia
- AI Algorithm - Supraventricular Tachycardia Product Overview
- Viz Pulmonary
- Viz Pulmonary Product Overview
- Viz.ai Inc - Key Competitors
- Viz.ai Inc - Key Employees
- Viz.ai Inc - Locations and Subsidiaries
- Head Office
- Recent Developments
- Viz.ai Inc, Recent Developments
- Jun 29, 2025: Viz.ai Receives FDA 510(k) Clearance for Viz Subdural Plus
- Apr 30, 2025: viz.ai Launches Viz 3D CTA to Deliver Enhanced Imaging and Accelerate Clinical Decision-Making
- Jan 07, 2025: Viz.ai Secures New Partnerships with Three Global Pharmaceutical Companies as Growth in Hospital Footprint Expands to 60,000 Providers
- Dec 16, 2024: Viz.ai Integrates Avicenna.AI's Tools for ASPECTS Stroke Severity Assessment and Incidental Pulmonary Embolism into Viz.ai One Platform
- Oct 21, 2024: viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients
- Sep 04, 2024: Viz.ai and Cleerly Announce Partnership
- Sep 04, 2024: Viz.ai Announces Partnership With Addario Lung Cancer Medical Institute
- Mar 12, 2024: Viz.ai Broadens Healthcare System Integrations to Inform Critical Decisions at the Point of Care
- Mar 07, 2024: New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism
- Feb 19, 2024: Viz.ai Receives 510(K) Clearance for Viz Volume Plus
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Viz.ai Inc Pipeline Products and Ongoing Clinical Trials Overview
- Viz.ai Inc Pipeline Products by Equipment Type
- Viz.ai Inc Pipeline Products by Indication
- Viz.ai Inc, Key Facts
- Viz.ai Inc, Major Products and Services
- Viz.ai Inc Number of Pipeline Products by Development Stage
- Viz.ai Inc Pipeline Products Summary by Development Stage
- AI Algorithm - Cardiac Amyloidosis - Product Status
- AI Algorithm - Cardiac Amyloidosis - Product Description
- AI Algorithm - Pulmonary Hypertension - Product Status
- AI Algorithm - Pulmonary Hypertension - Product Description
- AI Algorithm - Supraventricular Tachycardia - Product Status
- AI Algorithm - Supraventricular Tachycardia - Product Description
- Viz Pulmonary - Product Status
- Viz Pulmonary - Product Description
- Viz.ai Inc, Key Employees
- Glossary
- Viz.ai Inc Pipeline Products by Equipment Type
- Viz.ai Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Intelligencia Inc
- PathAI Inc
- Jeeva Informatics Solutions Inc
- Deep 6 AI
- ConcertAI LLC
- Subtle Medical Inc
